Release date: 2016-01-19
As in the first half of 2015, there is a good-looking project plan, and the era when a team that can tell stories can be fully funded has passed.
However, in this capital winter, there is still a large amount of investment funds in the field. For example, a good doctor was reported by the media not long ago to plan a round of financing. If the progress is smooth, the valuation will reach 3 billion to 40. Billions of dollars, and a number of investment institutions have participated in the inquiry. This means that if it is successfully financed, Ping An will fully surpass the $394 million financing it received in September 2015 and the registered network with a valuation above $1.5 billion. The valuation of mobile medical projects will hit a new high.
“The question that investors often care about is what does your project take to realize it?†Zeng Xiaojun, chief strategy officer and managing partner of Gao Tejia Investment Group, said in an interview: “Consumers hope to find a good doctor and simplify the process of seeing through you. The hospital hopes to make management more efficient through you; pharmaceutical and medical device manufacturers hope that you can conduct more precise targeted marketing. Mobile medical projects must generate value in the involved links before they are worth investing. "
In Zeng Xiaojun's view, among the many links involved in mobile medical care, health management, self-diagnosis, self-medication, clinical consultation, waiting for treatment, and out-of-hospital rehabilitation have been able to migrate from offline to online; while diagnosis, treatment, and in-hospital rehabilitation are higher. Technical barriers are also mainly offline.
"For the hospital, the core of the current situation is still to solve the treatment efficiency." Zeng Xiaojun expressed his opinion, "Whoever solves the problem is more efficient, and whoever has the possibility of realizing it."
In fact, the reporter of the “First Financial Daily†found in the interview that the liquidity and profit model have become the key to whether mobile medical projects can obtain ammunition in this capital winter.
“When we were in Series A financing, investors were most concerned about the general direction of the project. At that time, financing was easy, and now (B round) investors will pay more attention to some pragmatic aspects, all of which are related to cash flow. Realizing relevant issues." Sun Guangfeng, founder of the Oral Medical O2O platform, said in an interview that their B-round financing is nearing completion.
It is understood that in the field of mobile medical segmentation, the current good dental platform covers more than 80,000 doctors nationwide. Among them, APP registered doctors have reached more than 30,000 people, accounting for nearly one-third of the country's licensed dentists.
"In fact, it is not easy to have a new team to cut this piece of cake now, because capital is not willing to vote for you to burn money to grab doctors, they are beginning to pay attention to how to get returns." Sun Guangfeng revealed, "Taking good dentists as an example Previously, our layout focused on creating a transparent medical platform for patients, because patients know that looking at the 'more water', which can bring value to patients. On the other hand, provide customer management services to doctors and clinics. Reduce operating costs, build their brand and bring them customers."
Sun Guangfeng said that after obtaining the user's viscosity of patients and doctors and clinics, doctors and clinics can get more resources from the platform, and the dentist can get a small profit share from it. This is the core means of realizing the current dental platform. Of course, the large-scale supply of consumables and equipment is also one of the ways to achieve a good dental platform. In fact, these two are also the most influential investors.
According to Boston Consulting's estimates, by 2020, China's digital medical market will reach 700 billion yuan. In the first half of 2015, the total amount of domestic mobile medical ventures was nearly 800 million US dollars, exceeding the total of 4.5 billion yuan in 2014, and the number of mobile medical platforms nationwide has exceeded 2,000.
“In the early days, mobile medical care was built around the needs of doctors and patients to get user traffic as the core. But nowadays, portal integration, deep penetration of customer needs has become the core, and even some vertical user platforms will come out. The competition of large user platforms coexists. BAT and other companies will try to cut into the diagnosis and treatment services on the basis of the previous ones, and the realization becomes more and more important." Zeng Xiaojun said.
Source: Yicai.com
Ibuprofen Tablets And Capsules
Ibuprofen Tablets And Capsules,Ibuprofen Tablet,Painkiller Ibuprofen Tablets,Fda Ibuprofen Tablets
SHANDONG XINHUA PHARMACEUTICAL Co., Ltd. , https://www.sdxinhuapharm.com